Tissue therapies posts small loss
By Renate Krelle
Thursday, 10 February, 2005
Thursday, 10 February, 2005
Tissue Therapies Limited (ASX:TIS) has released its half-year results, recording a net loss of $445,400, in line with budget expectations.
At December 31, the company had cash reserves of almost $4 million, bolstered by a $1.5 million capital raising in October last year.
It spent $524,000 on research and development, and banked revenue of $152,5000 from research grants and interest.
Related News
TGA approves donanemab for treatment of early Alzheimer's
The TGA has approved the first amyloid-targeting therapy for people with Alzheimer's in...
Ultra-processed foods linked to poor health, premature death
Evidence suggests a dose-response relationship between ultra-processed food consumption and...
Shorter radiotherapy course proves safe for prostate cancer
A significantly shorter course of radiotherapy for localised prostate cancer is just as safe and...
